Mita, thanks for posting the article. It nailed the same issues I pointed out on the previous thread. The only thing that remains to be discussed, IMO, is how the IP and insurance proceeds will be divvy up between the lawyers, shareholders, regulators, and VCs.
Add to My Watchlist
What is My Watchlist?